Get started
SPRINGWORKS THERAPSPRINGWORKS THERAPSPRINGWORKS THERAP

SPRINGWORKS THERAP

No trades
See on Supercharts
Overview
Financials Discussions Forecast Seasonals

SWTX chart


Full chart

SWTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.81 B‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.018 CHF
Net income (FY)
‪−234.43 M‬ CHF
Revenue (FY)
‪174.00 M‬ CHF
Shares float
‪74.11 M‬
Beta (1Y)
1.01

Employees


Employees (FY)
368
Change (1Y)
+63 +20.66%
Revenue / Employee (1Y)
‪472.83 K‬ CHF
Net income / Employee (1Y)
‪−637.05 K‬ CHF

About SPRINGWORKS THERAP


Sector
Health Technology
Industry
Biotechnology
Website
springworkstx.com
Headquarters
Stamford
Founded
2017
FIGI
BBG01TNYSHR8
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.

Check out other big names from the same industry as SWTX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SPRINGWORKS THERAP stocks are traded under the ticker SWTX.
We've gathered analysts' opinions on SPRINGWORKS THERAP future price: according to them, SWTX price has a max estimate of 37.34 CHF and a min estimate of 37.34 CHF. Watch SWTX chart and read a more detailed SPRINGWORKS THERAP stock forecast: see what analysts think of SPRINGWORKS THERAP and suggest that you do with its stocks.
Yes, you can track SPRINGWORKS THERAP financials in yearly and quarterly reports right on TradingView.
SPRINGWORKS THERAP is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SWTX earnings for the last quarter are −0.82 CHF per share, whereas the estimation was −0.70 CHF resulting in a −16.81% surprise. The estimated earnings for the next quarter are −0.58 CHF per share. See more details about SPRINGWORKS THERAP earnings.
SPRINGWORKS THERAP revenue for the last quarter amounts to ‪52.65 M‬ CHF, despite the estimated figure of ‪58.16 M‬ CHF. In the next quarter, revenue is expected to reach ‪57.89 M‬ CHF.
SWTX net income for the last quarter is ‪−73.64 M‬ CHF, while the quarter before that showed ‪−70.20 M‬ CHF of net income which accounts for −4.90% change. Track more SPRINGWORKS THERAP financial stats to get the full picture.
No, SWTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 8, 2025, the company has 368 employees. See our rating of the largest employees — is SPRINGWORKS THERAP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SPRINGWORKS THERAP EBITDA is ‪−230.96 M‬ CHF, and current EBITDA margin is −143.36%. See more stats in SPRINGWORKS THERAP financial statements.
Like other stocks, SWTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPRINGWORKS THERAP stock right from TradingView charts — choose your broker and connect to your account.